Retatrutide
“The Triple Threat”
A next-gen triple-hormone agonist producing some of the biggest fat-loss numbers yet seen.
Retatrutide
Compound descriptor: GLP-1 / GIP / glucagon triple agonist
- 98
- FAT
- 96
- APPETI
- 90
- METABO
- Class
- Fat Loss & Metabolic
01 · THE SCORECARD
How it rates
Our totally-for-fun rating across the metrics beginners actually care about.
- Fat Loss Power
- 98 / 100
- Appetite Control
- 96 / 100
- Metabolic Boost
- 90 / 100
- Research Depth
- 68 / 100
Overall Grade
SCORE 94/100
02 · HOW IT WORKS
The mechanism
Hits three targets
It activates GLP-1, GIP, and glucagon receptors at the same time.
Hunger drops
You feel full sooner and think about food far less.
Fat burns faster
The glucagon action also nudges your body to burn more energy.
03 · WHY PEOPLE USE IT
The benefits
Powerful Fat Loss
Trial data shows category-leading weight reduction.
Appetite Suppression
Cravings and portion sizes drop dramatically.
Better Blood Sugar
Improves insulin sensitivity and glucose control.
Metabolic Uplift
Glucagon action raises overall energy burn.
05 · RELATED RESEARCH
Related compounds
Source-checked entry
Verified means the Research Lab entry has been checked against its cited sources. It does not mean the compound has been proven safe or effective for human use.
Research-use information
Nicknames, one-line descriptions, tiers, scores and the mechanism and benefit cards are a borrowed, just-for-fun ranking opinion — not clinically verified grades, results or safety guidance. Titan’s qualified research is in Science & References.
Educational research reference only. Not medical advice. Laboratory and animal findings do not establish effects in humans. Products supplied by Titan Labs Australia are for laboratory research use only and are not for human or animal consumption.
Last updated 2 Oct 2026